Figure S4. Power vs. Trial Arm Size in a Simulated Trial of Goldblatt et al. PCV13. Simulated under assumptions of less divergence between the efficacies of different dose schedules. Sample sizes for a 3 + 1 vs 2 + 1 trial are not calculated because doing so would be incoherent; the arms are essentially identical, which implies an infinite theoretical sample size. (JPG 225 kb
Results of tuning RF model parameter mtry, number of variables randomly sampled as candidates at eac...
Additional file 1: Table S1. Characteristics of participants with breakthrough infections, post-vacc...
<p>Simulations were performed for each combination of vaccine type (erythrocytic or hepatic), effica...
Figure S2. Simulated Trial of Goldblatt et al. PCV13 in a 3 + 1 Vaccinated Population. Vaccine trial...
Figure S3. Relative Vaccine Efficacies of Goldblatt et al. PCV13 in a Simulated Trial. Relative vacc...
Figure S5. Serotype-specific Prevalence Distribution After Fitting Model. Prevalence of each serotyp...
Lactate dehydrogenase (LDH) levels in bronchioalveolar lavage (BAL) fluid (A), 8-isoprostane levels ...
For encapsulated bacteria such as Streptococcus pneumoniae, asymptomatic carriage is more common and...
Abstract Background There is great interest in the use of reduced dosing schedules for pneumococcal ...
Adjusted analysis of the association of different variables with the vaccine era using linear mixed ...
Table S1A-7. Data stratified per group for complementary experimental groups. All data is measured a...
Initial antibody titers per group. Prior to immunization, Efb and LukM specific antibody titers in s...
Figure S2. NETs and bacterial burden in patients with VAP. Bacterial colony counts from quantitative...
Additional file 1: Supplemental Figure S1. Vaccine roll-out scenarios. Supplemental Figure S2. Impac...
Proliferation of gamma delta T-cells following stimulation with LukM and EfB. Proliferation was meas...
Results of tuning RF model parameter mtry, number of variables randomly sampled as candidates at eac...
Additional file 1: Table S1. Characteristics of participants with breakthrough infections, post-vacc...
<p>Simulations were performed for each combination of vaccine type (erythrocytic or hepatic), effica...
Figure S2. Simulated Trial of Goldblatt et al. PCV13 in a 3 + 1 Vaccinated Population. Vaccine trial...
Figure S3. Relative Vaccine Efficacies of Goldblatt et al. PCV13 in a Simulated Trial. Relative vacc...
Figure S5. Serotype-specific Prevalence Distribution After Fitting Model. Prevalence of each serotyp...
Lactate dehydrogenase (LDH) levels in bronchioalveolar lavage (BAL) fluid (A), 8-isoprostane levels ...
For encapsulated bacteria such as Streptococcus pneumoniae, asymptomatic carriage is more common and...
Abstract Background There is great interest in the use of reduced dosing schedules for pneumococcal ...
Adjusted analysis of the association of different variables with the vaccine era using linear mixed ...
Table S1A-7. Data stratified per group for complementary experimental groups. All data is measured a...
Initial antibody titers per group. Prior to immunization, Efb and LukM specific antibody titers in s...
Figure S2. NETs and bacterial burden in patients with VAP. Bacterial colony counts from quantitative...
Additional file 1: Supplemental Figure S1. Vaccine roll-out scenarios. Supplemental Figure S2. Impac...
Proliferation of gamma delta T-cells following stimulation with LukM and EfB. Proliferation was meas...
Results of tuning RF model parameter mtry, number of variables randomly sampled as candidates at eac...
Additional file 1: Table S1. Characteristics of participants with breakthrough infections, post-vacc...
<p>Simulations were performed for each combination of vaccine type (erythrocytic or hepatic), effica...